It's weird because here...I went to Dublin last year but was refused treatment as I have high frequency hearing loss. Neuromod had not reported that this treatment would be unsuitable and only made it known post my trip.
There are other treatments on the way so don't despair.
Having used the UMich device and having a strong layman's understanding of how it works, I can think of no reason this wouldn't work if your aid-corrected thresholds were sufficient to hear the beeps.But is it not possible to put the headphones on top of my hearing aids????
I listen to my music like this and it works very well, I don't understand...
Thank you for your reply, it gives me some hope!Having used the UMich device and having a strong layman's understanding of how it works, I can think of no reason this wouldn't work if your aid-corrected thresholds were sufficient to hear the beeps.
This is just another thing in the long list of claims Lenire has made, along with their very dubious choice to use wireless headphones on a medical device where latency in the ms range matters, which makes me skeptical that their tech is as good as the more solidly research-backed devices which have yet to see market.
You have used the UMich device? Were you in a trial? How long did you use it for and what type of results did you have?Having used the UMich device and having a strong layman's understanding of how it works, I can think of no reason this wouldn't work if your aid-corrected thresholds were sufficient to hear the beeps.
This is just another thing in the long list of claims Lenire has made, along with their very dubious choice to use wireless headphones on a medical device where latency in the ms range matters, which makes me skeptical that their tech is as good as the more solidly research-backed devices which have yet to see market.
Yes -- I posted about it pretty extensively in the UMich thread in the Research News category. I believe you would want to look at that thread from the timeframe of 1/1/2016 - 6/1/2016 to see what I had to say about it at the time.You have used the UMich device? Were you in a trial? How long did you use it for and what type of results did you have?
Clinical trial data on efficacy, never mind side-effects and worsening, is not mandatory for device approval in the EU.@kelpiemsp wasn't using Lenire so his experience is only relevant for evaluating neuromodulation in general, not Lenire.
I do have a problem with a company barreling forward with releasing a product without peer review and with this high of a "disimprovement" rate. It's reckless and it turns me off regardless of whether it's considered legal in the EU.
This is not to invalidate those who feel it's helped them, but just as they're pausing some of the COVID-19 vaccines due to what are often a scant number of negative side effects I don't see how it is a device like this can win EU approval with a 20% chance of having your tinnitus symptoms worsen.
I don't know the rationale but it may be that regulators feel that having your tinnitus worsen is no big deal even though we have at least one suicide on record potentially as a result of it.
Thanks, did not realize you had posted it elsewhere!Yes -- I posted about it pretty extensively in the UMich thread in the Research News category. I believe you would want to look at that thread from the timeframe of 1/1/2016 - 6/1/2016 to see what I had to say about it at the time.
Sorry to redirect you to another thread, but the stuff I had to say about the treatment at the time is probably a lot more interesting than my memories from 5 years later.
The TL;DR is, I think it works, and if someone gave me an opportunity today to buy the experimental device I used for $10,000, I would do so.
But, I am not yet willing to spend even a fraction of that on Lenire, they got some splainin' to do as far as I am concerned.
thanks to whatever kind moderator or admin turned my text into a link to the thread!Thanks, did not realize you had posted it elsewhere!
Yeah, this is why I'm not very interested in Lenire until they clear FDA process. Or not.Clinical trial data on efficacy, never mind side-effects and worsening, is not mandatory for device approval in the EU.
It's very wrong.
The next gen of this needs to come with a user-friendly EEG kit - you run the EEG and either via teleconference with a Lenire employee or a self-guided app, the device is configured with timings unique to your biometric data. My fear is this being a medical device and not a consumer electronic, iteration cycles will be looooooooooooooooooong.thanks to whatever kind moderator or admin turned my text into a link to the thread!
Yeah, this is why I'm not very interested in Lenire until they clear FDA process. Or not.
Also note - the approval they DO have in Ireland is from 2015 based on the previous version of the device. This also, likely, would not be acceptable to the FDA.
But, I am not yet willing to spend even a fraction of that on Lenire, they got some splainin' to do as far as I am concerned.
It's the dissonance in this research that never ceases to confound me. Even in the above two paragraphs it's there: "No serious treatment-related adverse events occurred with the device" as an addendum to, "about a fifth of participants experienced no change or a worsening of symptoms". Do they really believe that using their device and experiencing a worsening of symptoms is not an adverse event?Overall, tinnitus symptom severity significantly improved, although about a fifth of participants experienced no change or a worsening of symptoms. Two groups that received neuromodulation using higher-frequency tones with synchronized or shorter delayed tongue stimulation had sustained improvements over 12 months.
No serious treatment-related adverse events (AEs) occurred with the device. Most participants adhered to the treatment and said they benefited from it. "These high compliance and satisfaction rates, when compared to the reported AEs, support a strong benefit-to-risk profile for this medical device treatment for tinnitus," the authors wrote.
Source: https://jamanetwork.com/journals/jama/article-abstract/2772741
"helped" people part with their cash probably.To UKBloke:
Very insightful regarding the use of such self-protective terms to camouflage the real minimal or deleterious effects.
In Lenire's case, there was even an incomprehensible, slipshod lack of awareness regarding the obvious contradiction you mentioned.
I noticed that Julian Cowan Hill employs such nonspecific language so that he cannot be cited when his treatments are ineffective. He will, for example, contend that it is "definitely possible" to completely cure tinnitus, or that he has "helped" hundreds of clients. Such calculated, nonspecific expressions ("helped" can mean virtually anything) are evasions about the real utility of his methods.
Let's see if Lenire actually receives FDA approval, and if so whether my rigorously science-based ENT Doctor recommends it.
I would think Lenire would face stricter scrutiny under Biden's tenure than Trump's hydroxychloroquine administration.Let's see if Lenire actually receives FDA approval, and if so whether my rigorously science-based ENT Doctor recommends it.
Please record your impressions and share with all of us what they said.For the Germans (I guess the presentation will be in German language), there is a Webinar planned by two tinnitus experts in Germany. They are talking about Lenire. They do some presentations about "promising results" with Lenire. They explain how Lenire works and patients report about their experiences. Also a Q&A is planned.
I have subscribed and will attend.
I guess honesty is a little too much to ask.He is there to promote it I think.
He also benefits financially from Lenire, does he not???Why do you think Berthold Langguth would criticize Neuromod?
He is there to promote it I think.
I don't think so.Does anyone feel like meeting Neuromod face to face is essential?